ASSOCIATION BETWEEN GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER IN ADULTS AND THE DEVELOPMENT OF PERIODONTAL CHANGES AND DENTAL CARIES: SYSTEMATIC REVIEW AND META-ANALYSIS.

J Evid Based Dent PractMar 15, 2026 (epub)
Clinical ResearchGastroenterology

Maria Cláudia Alves, Isadora França Vieira-Silva, Olívia Francescato et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined associations between gastroesophageal reflux disease (GERD) or peptic ulcer and dental caries or periodontal disease. Nineteen studies were eligible, with data from 10 included in six meta-analyses. Compared with people without GERD, those with GERD had a higher DMFT index (MD = 0.79; 95% CI = 0.00, 1.57; k = 5), as well as higher PMA and OHI-S indices. The authors concluded that GERD and peptic ulcer were associated with greater likelihood of caries and periodontal disease, while noting that the evidence base included few studies.

Key findings

  • GERD was associated with a higher DMFT index than no GERD (MD = 0.79; 95% CI = 0.00, 1.57; k = 5).
  • The PMA index was higher in people with GERD (MD = 1.00; 95% CI = 0.60, 1.40; k = 2).
  • The OHI-S index was higher in people with GERD (MD = 1.22; 95% CI = 0.50, 1.93; k = 2).
  • Nineteen studies were eligible, but only 10 contributed data to the six meta-analyses.

Why it matters

The findings suggest that GERD and peptic ulcer may coexist with greater caries and periodontal burden. Awareness of this reported association can support consideration of oral health when assessing patients with these conditions, while the limited number of studies contributing to pooled analyses means the estimates should be interpreted cautiously.

What to keep in mind

The authors note that the evidence and meta-analyses were based on few studies; only 10 of the 19 eligible studies contributed data to pooled analyses.

Source

Published in J Evid Based Dent Pract. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.